Indication
Same as Nuketo® - for prevention and therapy of damage due to faulty or deficient protein metabolism in chronic renal insufficiency.
Mechanism of action
As for Nuketo® - see entry above.
Strengths
- •Double-strength tablet
Composition
Each Nuketo®-DS tablet contains: Calcium 3-methyl-2-oxovalerate 134 mg; Calcium 4-methyl-2-oxovalerate 202 mg; Calcium 2-oxo-3-phenylpropionate 136 mg; Calcium 3-methyl-2-oxobutyrate 172 mg; Calcium DL-2-hydroxy-4-(methylthio)butyrate 118 mg; L-Lysine acetate USP 210 mg; L-Threonine USP 106 mg; L-Tryptophan USP 46 mg; L-Histidine USP 76 mg; L-Tyrosine USP 60 mg. Total nitrogen per tablet: 72 mg. Calcium per tablet: 2.50 mmol (≈ 0.05 g).
Presentation
Alu-alu blister pack of 10 tablets in one strip, 10 strips in a box.
For Healthcare Professionals
Recommended dose: one tablet per 10 kg body weight per day, taken during meals, for the duration prescribed.
This section is intended for use by registered medical practitioners only. All clinical decisions remain the prescriber's responsibility and should be informed by the current approved product label.
Notes for patients & caregivers
Same as Nuketo® - take with meals, follow your diet plan exactly as advised by your nephrologist and dietician.
These notes are for general awareness only and are not a substitute for medical advice. Please follow your treating physician's instructions and the directions on the dispensed product.
Storage
Store below 25°C.
Important
- • Nuketo-DS® is a prescription medicine. It must only be used on the advice of a registered medical practitioner.
- • Always refer to the current approved Indian product label / package insert for definitive prescribing information.
- • If you experience any quality or safety concern, please contact us or write to info@vyapitus.com.